gr 65630 has been researched along with domperidone in 1 studies
Studies (gr 65630) | Trials (gr 65630) | Recent Studies (post-2010) (gr 65630) | Studies (domperidone) | Trials (domperidone) | Recent Studies (post-2010) (domperidone) |
---|---|---|---|---|---|
57 | 0 | 4 | 1,977 | 275 | 468 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirokawa, Y; Kato, S; Morie, T; Yamazaki, H; Yoshida, N | 1 |
1 other study(ies) available for gr 65630 and domperidone
Article | Year |
---|---|
A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors.
Topics: Animals; Benzamides; Binding Sites; Cerebral Cortex; Corpus Striatum; Domperidone; Dopamine Antagonists; Imidazoles; Indoles; Ligands; Metoclopramide; Models, Chemical; Ondansetron; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Spiperone; Stereoisomerism | 1998 |